Companies: 10,795·Total market cap: $144.5T
Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc.

NAUTNASDAQHealthcare● Active
$2.33
$-0.06(-2.51%)
Market Cap$296093732
P/E Ratio
52W High$4.31
52W Low$0.62

Nautilus Biotechnology, Inc. (NAUT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · NAUT · as of Jun 8, 2026

Activity summary

Buy transactions

5

P-Purchase only

Sell transactions

2

12 Months

Buy/Sell ratio

2.50

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 71%Active transactions only · RSU vesting excluded29% Sell ↓

Nautilus Biotechnology, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

NAUT insider buying and selling by quarter

NAUT insider selling · NAUT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
5.0M2.5M0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · NAUT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

NAUT executive sell shares · NAUT board member insider trading · NAUT insider trading SEC filing

Showing 30 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

AH Equity Partners Bio II, L.L.C.

10 percent owner

Sale

Date

Jun 2

Shares

4,615,974

Price

$2.35

Value

$10.85M ⚡

View Form 4 on SEC.gov

AH Equity Partners Bio II, L.L.C.

10 percent owner

Sale

Date

Jun 2

Shares

384,026

Price

$2.35

Value

$902K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 4

Shares

25,000

Price

$2.61

Value

$65K

View Form 4 on SEC.gov

Suzuki Kentaro

Chief Marketing Officer

Purchase

Date

Nov 6

Shares

4,000

Price

$1.49

Value

$6K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Sep 8

Shares

83,500

Price

$0.68

Value

$57K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Sep 5

Shares

116,500

Price

$0.67

Value

$79K

View Form 4 on SEC.gov

Murphy Matthew B.

General Counsel

Purchase

Date

Sep 4

Shares

20,000

Price

$0.64

Value

$13K

View Form 4 on SEC.gov

Mowry Anna

CFO and Treasurer

Purchase

Date

May 29

Shares

15,000

Price

$0.77

Value

$11K

View Form 4 on SEC.gov

Mallick Parag

Chief Scientist · Director

Purchase

Date

May 12

Shares

1,500

Price

$0.73

Value

$1K

View Form 4 on SEC.gov

Mallick Parag

Chief Scientist · Director

Purchase

Date

May 8

Shares

12,000

Price

$0.73

Value

$9K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 20

Shares

23,933

Price

$1.00

Value

$24K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 19

Shares

53,300

Price

$0.99

Value

$53K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Option

Date

Sep 23

Shares

47,031

Price

$0.46

Value

$22K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Sale

Date

Sep 23

Shares

47,031

Price

$2.87

Value

$135K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Option

Date

Sep 17

Shares

35,000

Price

$0.46

Value

$16K

View Form 4 on SEC.gov

Godwin Mary E.

Senior VP, Operations

Sale

Date

Sep 17

Shares

35,000

Price

$2.85

Value

$100K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 11

Shares

12,044

Price

$2.84

Value

$34K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 8

Shares

2,430

Price

$2.99

Value

$7K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 7

Shares

18,854

Price

$2.89

Value

$54K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 6

Shares

9,267

Price

$2.70

Value

$25K

View Form 4 on SEC.gov

Patel Sujal M

CEO, President, and Secretary · Director

Purchase

Date

Mar 5

Shares

7,405

Price

$2.65

Value

$20K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

Date

Sep 27

Shares

5,000

Price

$2.03

Value

$10K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

Date

Sep 26

Shares

10,000

Price

$2.02

Value

$20K

View Form 4 on SEC.gov

Weld Gwen E

CPO

Purchase

Date

Sep 23

Shares

30,000

Price

$2.03

Value

$61K

View Form 4 on SEC.gov

Sankar Subramanian

Senior VP, Product Development

Purchase

Date

Sep 16

Shares

35,000

Price

$2.16

Value

$75K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About NAUT insider trading

NAUT insider trades

Nautilus Biotechnology, Inc. (NAUT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer). Over the past 12 months, 4 insiders have filed transactions with the SEC. NAUT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Nautilus Biotechnology, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

NAUT insider trading · 5 questions

The insiders of Nautilus Biotechnology, Inc. (NAUT) include executives and directors such as Patel Sujal M (CEO, President, and Secretary · Director), AH Equity Partners Bio II, L.L.C. (10 percent owner), Suzuki Kentaro (Chief Marketing Officer), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

NAUT board member insider tradingwho are NAUT insidersNAUT insider rosterNautilus Biotechnology, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026